Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+17.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+17.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 79.60% |
| 2023 | 47.69% |
| 2022 | -11.21% |
| 2021 | 49.62% |
| 2020 | 29.08% |
| 2019 | -4.83% |
| 2018 | -20.05% |
| 2017 | -62.85% |
| 2016 | 0.00% |